Corporate calendar for AC Immune S.A. (ACIU): upcoming earnings dates, dividend ex-dates and payment dates, stock splits, shareholder meetings and conference calls. Plan your positions around the key catalysts.
AC Immune S.A. is a biotech firm operating at the clinical stage, dedicated to pioneering, formulating, and advancing therapeutic agents and diagnostic tools. Its core mission is addressing neurodegenerative conditions rooted in protein misfolding, both preventatively and therapeutically.
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|---|---|
| 2026-09-14 | ||
| 2026-09-14 | ||
| 2026-09-14 | ||
| 2026-09-14 | $-0.72 | |
| 2026-09-14 | $1M | |
| 2026-09-14 |
Price
| Price | $2.65 |
| Market Cap | $270M |
| Exchange | NASDAQ |
| Country | CH |
Analyst Consensus
| Strong Buy | 0 |
| Buy | 8 |
| Hold | 1 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 9 |
| Avg rating (1-5) | 0.89 |
Related companies: ALDX · AMRN · ANNX · ANRO · CLLS · CTNM · DRTS
Explore sector: Healthcare · Biotechnology
More sections of ACIU: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · News
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks